Physician profile
David J Dexter
NPI 1649306853
$404,393.79
in general payments reported to CMS, 2019-2025
55 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $143K · 2020: $59K · 2021: $44K · 2022: $80K · 2023: $41K · 2024: $22K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29K · Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $5,268 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28,850.77 |
| Consulting Fee | $23,870.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,360.00 |
| Travel and Lodging | $5,267.67 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $142,976.13 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $56,050.65 | 2019-2025 | Opticross 35, Angiojet Ultra 5000a, General - Vascular Intervention |
| Penumbra, INC. | $48,799.70 | 2019-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $33,052.04 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Bard Peripheral Vascular, INC. | $23,578.96 | 2019-2025 | Venovo, Crosser Iq, True Flow |
| Cardiovascular Systems INC. | $15,778.17 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| W. L. Gore & Associates, INC. | $12,372.36 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Product In Development |
| Medtronic Vascular, INC. | $10,037.16 | 2019-2020 | |
| Medtronic, INC. | $7,347.87 | 2021-2025 | Endurant Iis, Hawkone, Abre |
| Osiris Therapeutics INC. | $7,203.95 | 2019 | |
| Bolton Medical INC | $6,407.02 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Gelweave |
| Contego Medical, INC | $6,307.86 | 2022-2025 | |
| C. R. Bard, INC. & Subsidiaries | $4,200.00 | 2020 | |
| Angiodynamics, INC. | $4,050.22 | 2019-2024 | Venacure 1470 Pro |
| Cook Incorporated | $3,720.00 | 2025 | Zenith Spiral-Z |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,823.63 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Philips North America LLC | $2,714.52 | 2022-2025 | (6554) Periph Vasc Undiv, (Bs1) Peripheral Vascular Undivided, (Br5) Peripheral Ivus |
| Mercator Medsystems, INC. | $2,623.38 | 2021-2024 | Bullfrog, Leapfrog Micro-Infusion Device |
| Abbott Laboratories | $2,580.53 | 2019-2025 | Esprit, Jeti, Perclose Proglide |
| Cook Medical LLC | $2,411.20 | 2019-2025 | Zenith Spiral-Z, Cook, Zilver Vena |
| Imperative Care, INC | $1,540.54 | 2023-2025 | Symphony Catheter, Prodigy Catheter |
| Silk Road Medical, INC. | $1,454.58 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $1,353.39 | 2019-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Limflow INC. | $982.73 | 2023 | Limflow System |
| Shockwave Medical, INC | $758.21 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inspiremd LTD | $489.30 | 2024-2025 | Cguard Prime Carotid Stent System, Cguard |
| Avantec Vascular Corporation | $354.11 | 2023-2024 | |
| Reflow Medical INC | $264.91 | 2025 | |
| Cordis US Corp. | $199.32 | 2021-2022 | |
| Shape Memory Medical INC. | $192.52 | 2025 | Impede Embolization Plug |
| Baxter Healthcare | $166.18 | 2023 | Preveleak |
| Ge Healthcare | $159.67 | 2023 | |
| Smith+Nephew, INC. | $158.92 | 2020-2023 | Pico, Renasys Go V2 Home, Renasys Touch |
| Devoro Medical INC. | $133.18 | 2021 | |
| Cvrx, INC. | $130.71 | 2019-2023 | Barostim Neo System |
| Vesper Medical | $128.92 | 2021 | |
| Cagent Vascular INC | $125.50 | 2024 | Serrantor |
| Janssen Scientific Affairs, LLC | $124.49 | 2019 | |
| Surmodics, INC. | $119.22 | 2024 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Kci USA, INC. | $112.62 | 2020 | |
| Thrombolex, INC. | $63.07 | 2023 | |
| Inquis Medical, INC. | $57.80 | 2025 | Aventus |
| Getinge USA Sales, LLC | $52.97 | 2019 | |
| Intuitive Surgical, INC. | $52.91 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $47.00 | 2022 | |
| Sanara Medtech INC. | $39.81 | 2022 | |
| Mallinckrodt Hospital Products INC. | $30.06 | 2025 | Terlivaz |
| Tactile Systems Technology INC | $17.46 | 2021 | |
| Terumo Medical Corporation | $17.44 | 2021 | |
| Cardiva Medical, INC. | $14.17 | 2023 | Cardiva Vascade 6/7f Vcs |
| Lemaitre Vascular, INC. | $14.12 | 2023 | Hydro Lemaitre Valvulotome |
| Organogenesis INC. | $2.61 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,326.75 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dexter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.